A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma Journal Article
| Authors: | Korde, N.; Carlsten, M.; Lee, M. J.; Minter, A.; Tan, E.; Kwok, M.; Manasanch, E.; Bhutani, M.; Tageja, N.; Roschewski, M.; Zingone, A.; Costello, R.; Mulquin, M.; Zuchlinski, D.; Maric, I.; Calvo, K. R.; Braylan, R.; Tembhare, P.; Yuan, C.; Stetler-Stevenson, M.; Trepel, J.; Childs, R.; Landgren, O. |
| Article Title: | A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma |
| Keywords: | protein expression; treatment response; unclassified drug; human cell; clinical feature; disease course; diarrhea; outcome assessment; follow up; letter; multiple cycle treatment; multiple myeloma; nausea; protein; creatinine; cytotoxicity; monoclonal antibody; chill; fever; alanine aminotransferase; aspartate aminotransferase; immune response; clinical evaluation; natural killer cell; clinical response; m protein; gastrointestinal disease; abdominal discomfort; smoldering multiple myeloma; human; hla-c binding kir2d reports; iph2101; kir2d blockade; nk-cell function; kir2d |
| Journal Title: | Haematologica |
| Volume: | 99 |
| Issue: | 6 |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2014-06-01 |
| Start Page: | e81 |
| End Page: | e83 |
| Language: | English |
| DOI: | 10.3324/haematol.2013.103085 |
| PROVIDER: | scopus |
| PMCID: | PMC4040899 |
| PUBMED: | 24658821 |
| DOI/URL: | |
| Notes: | Haematologica -- Export Date: 8 July 2014 -- CODEN: HAEMA -- Source: Scopus |
